BI-2081 | BI-2081 : Agonist of FFAR1
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (2 reviews)
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
FFAR1
  • Ki:23 nM
  • EC50:3-5 nM
Agonist
extracellular target
up to 200 nM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Eurofins Safety Panel (44 GPCRs at 10 μM): Closest off-targets (Kd [µM]): ADRA2C (0.840), ADRA2A (1. ...

Potency
Cellular
In Vitro

FFAR1

Mode of Action: Agonist

Structure-Activity-Relationship data available? No

Other Reference: Peer reviewed at SGC

In Vivo Validations

Rat
Dose: 1 mg/Kg IV, 10 mg/Kg PO
Route of delivery: Intravenous, Oral
Systemic clearance: 6.9% QH
Tmax: 1.17 h
Bioavailability: 79%
Volume of Distribution at Steady-State: 0.9 L/Kg

Other Reference: Peer reviewed at SGC

Negative Control Compounds

CANSAR3894697
Notes: BI-0340: EC50 = 1230 nM (human IPOne assay); Eurofins Safety Panel 44™: clean (closest off-target: NR3C1 (57 % inh. at 10 µM))

Orthogonal Probes def

CANSAR735732

Chemical Information

Molecular Formula C32H35FO6
SMILEs Cc1cc(OCCC(C)(C)O)cc(C)c1-c1ccc(F)c2c1CC[C@H]2Oc1ccc2c(c1)OC[C@H]2CC(=O)O
InChI InChI=1S/C32H35FO6/c1-18-13-22(37-12-11-32(3,4)36)14-19(2)30(18)24-7-9-26(33)31-25(24)8-10-27(31)39-21-5-6-23-20(15-29(34)35)17-38-28(23)16-21/h5-7,9,13-14,16,20,27,36H,8,10-12,15,17H2,1-4H3,(H,34,35)/t20-,27-/m1/s1
Molecular weight 534.24 Da
AlogP 0.0
HBond acceptors 6
HBond donors 2
Atoms 74

Expert Reviews


(on 19 Feb 2024)
In Model Organisms
(The reviewer did not leave any public comments)
(on 14 Oct 2025)
Cellular Use Rating
In Model Organisms
This is a well validated for in cell probe use. The in vivo data lack demonstration of target engagement, but PK properties reported and favorable.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria